Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 535

1.

The potential of tumor-derived exosomes for noninvasive cancer monitoring.

Whiteside TL.

Expert Rev Mol Diagn. 2015 Aug 2:1-18. [Epub ahead of print]

PMID:
26235194
2.

Exosomes isolated from plasma of glioma patients enrolled in a vaccination trial reflect antitumor immune activity and might predict survival.

Muller L, Muller-Haegele S, Mitsuhashi M, Gooding W, Okada H, Whiteside TL.

Oncoimmunology. 2015 Mar 2;4(6):e1008347. eCollection 2015 Jun.

PMID:
26155415
3.

Immunotherapy for acute leukemia.

Boyiadzis M, Whiteside TL, Pavletic SZ.

Aging (Albany NY). 2015 Jun;7(6):354-5. No abstract available.

4.

Consensus nomenclature for CD8+ T cell phenotypes in cancer.

Apetoh L, Smyth MJ, Drake CG, Abastado JP, Apte RN, Ayyoub M, Blay JY, Bonneville M, Butterfield LH, Caignard A, Castelli C, Cavallo F, Celis E, Chen L, Colombo MP, Comin-Anduix B, Coukos G, Dhodapkar MV, Dranoff G, Frazer IH, Fridman WH, Gabrilovich DI, Gilboa E, Gnjatic S, Jäger D, Kalinski P, Kaufman HL, Kiessling R, Kirkwood J, Knuth A, Liblau R, Lotze MT, Lugli E, Marincola F, Melero I, Melief CJ, Mempel TR, Mittendorf EA, Odun K, Overwijk WW, Palucka AK, Parmiani G, Ribas A, Romero P, Schreiber RD, Schuler G, Srivastava PK, Tartour E, Valmori D, van der Burg SH, van der Bruggen P, van den Eynde BJ, Wang E, Zou W, Whiteside TL, Speiser DE, Pardoll DM, Restifo NP, Anderson AC.

Oncoimmunology. 2015 Feb 25;4(4):e998538. eCollection 2015 Apr.

PMID:
26137416
5.

Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry.

Santegoets SJ, Dijkgraaf EM, Battaglia A, Beckhove P, Britten CM, Gallimore A, Godkin A, Gouttefangeas C, de Gruijl TD, Koenen HJ, Scheffold A, Shevach EM, Staats J, Taskén K, Whiteside TL, Kroep JR, Welters MJ, van der Burg SH.

Cancer Immunol Immunother. 2015 Jun 28. [Epub ahead of print]

PMID:
26122357
6.

Programmed death-1 checkpoint blockade in acute myeloid leukemia.

Sehgal A, Whiteside TL, Boyiadzis M.

Expert Opin Biol Ther. 2015 Aug;15(8):1191-203. doi: 10.1517/14712598.2015.1051028. Epub 2015 Jun 3.

PMID:
26036819
7.

CTLA-4⁺ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis.

Jie HB, Schuler PJ, Lee SC, Srivastava RM, Argiris A, Ferrone S, Whiteside TL, Ferris RL.

Cancer Res. 2015 Jun 1;75(11):2200-10. doi: 10.1158/0008-5472.CAN-14-2788. Epub 2015 Apr 1.

PMID:
25832655
8.

Dendritic cell-based autologous tumor vaccines for head and neck squamous cell carcinoma.

Whiteside TL, Ferris RL, Szczepanski M, Tublin M, Kiss J, Johnson R, Johnson JT.

Head Neck. 2015 Mar 3. doi: 10.1002/hed.24025. [Epub ahead of print]

PMID:
25735641
9.

Chondroitin sulfate proteoglycan-4 (CSPG4)-specific monoclonal antibody 225.28 in detection of acute myeloid leukemia blasts.

Fenton M, Whiteside TL, Ferrone S, Boyiadzis M.

Oncol Res. 2015;22(2):117-21. doi: 10.3727/096504014X14174484758503.

PMID:
25706398
10.

Information transfer by exosomes: A new frontier in hematologic malignancies.

Boyiadzis M, Whiteside TL.

Blood Rev. 2015 Jan 30. pii: S0268-960X(15)00013-2. doi: 10.1016/j.blre.2015.01.004. [Epub ahead of print]

PMID:
25686749
11.

Classification of current anticancer immunotherapies.

Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, Bracci L, Caignard A, Castelli C, Cavallo F, Celis E, Cerundolo V, Clayton A, Colombo MP, Coussens L, Dhodapkar MV, Eggermont AM, Fearon DT, Fridman WH, Fučíková J, Gabrilovich DI, Galon J, Garg A, Ghiringhelli F, Giaccone G, Gilboa E, Gnjatic S, Hoos A, Hosmalin A, Jäger D, Kalinski P, Kärre K, Kepp O, Kiessling R, Kirkwood JM, Klein E, Knuth A, Lewis CE, Liblau R, Lotze MT, Lugli E, Mach JP, Mattei F, Mavilio D, Melero I, Melief CJ, Mittendorf EA, Moretta L, Odunsi A, Okada H, Palucka AK, Peter ME, Pienta KJ, Porgador A, Prendergast GC, Rabinovich GA, Restifo NP, Rizvi N, Sautès-Fridman C, Schreiber H, Seliger B, Shiku H, Silva-Santos B, Smyth MJ, Speiser DE, Spisek R, Srivastava PK, Talmadge JE, Tartour E, Van Der Burg SH, Van Den Eynde BJ, Vile R, Wagner H, Weber JS, Whiteside TL, Wolchok JD, Zitvogel L, Zou W, Kroemer G.

Oncotarget. 2014 Dec 30;5(24):12472-508.

12.

Clinical Impact of Regulatory T cells (Treg) in Cancer and HIV.

Whiteside TL.

Cancer Microenviron. 2014 Nov 12. [Epub ahead of print]

PMID:
25385463
13.

Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis.

Szczepanski MJ, Luczak M, Olszewska E, Molinska-Glura M, Zagor M, Krzeski A, Skarzynski H, Misiak J, Dzaman K, Bilusiak M, Kopec T, Leszczynska M, Witmanowski H, Whiteside TL.

J Mol Med (Berl). 2015 Mar;93(3):305-14. doi: 10.1007/s00109-014-1217-3. Epub 2014 Nov 12.

14.

Biological Effects of Anti-Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Antibody Formation in Patients Treated With GM-CSF (Sargramostim) as Adjuvant Therapy of Melanoma.

Spitler LE, Cao H, Piironen T, Whiteside TL, Weber RW, Cruickshank S.

Am J Clin Oncol. 2014 Oct 3. [Epub ahead of print]

PMID:
25286079
15.

Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia.

Hong CS, Muller L, Boyiadzis M, Whiteside TL.

PLoS One. 2014 Aug 5;9(8):e103310. doi: 10.1371/journal.pone.0103310. eCollection 2014.

16.

Isolation of biologically-active exosomes from human plasma.

Muller L, Hong CS, Stolz DB, Watkins SC, Whiteside TL.

J Immunol Methods. 2014 Sep;411:55-65. doi: 10.1016/j.jim.2014.06.007. Epub 2014 Jun 18.

PMID:
24952243
17.

Measurements of natural killer (NK) cells.

Butterfield LH, Whiteside TL.

Crit Rev Oncog. 2014;19(1-2):47-55. Review.

PMID:
24941372
18.

Induced regulatory T cells in inhibitory microenvironments created by cancer.

Whiteside TL.

Expert Opin Biol Ther. 2014 Oct;14(10):1411-25. doi: 10.1517/14712598.2014.927432. Epub 2014 Jun 17. Review.

19.

Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and nonbrainstem gliomas.

Pollack IF, Jakacki RI, Butterfield LH, Hamilton RL, Panigrahy A, Potter DM, Connelly AK, Dibridge SA, Whiteside TL, Okada H.

J Clin Oncol. 2014 Jul 1;32(19):2050-8. doi: 10.1200/JCO.2013.54.0526. Epub 2014 Jun 2.

20.

Immunoregulatory activity of adenosine and its role in human cancer progression.

Muller-Haegele S, Muller L, Whiteside TL.

Expert Rev Clin Immunol. 2014 Jul;10(7):897-914. doi: 10.1586/1744666X.2014.915739. Epub 2014 May 29. Review.

PMID:
24871693
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk